Squamous Intraepithelial Neoplasia of the Upper Aerodigestive Tract

Diagnostic Surgical Pathology of the Head and Neck

Volumn , Issue , 2009, Pages 1-44

  Sakr, Wael A ^a   Gale, Nina ^b   Gnepp, Douglas R ^c   Crissman, John D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79951675349     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-2589-4.00001-2     Document Type: Chapter

References (262)

1. Mithani SK, Mydlarz WK, Grumbine FL, et al. Molecular genetics of premalignant oral lesions. Oral Dis 2007, 13:126-133.
2. Ustundag E, Kaur AC, Boyaci Z, et al. Combined use of histopathology with touch smear cytology in biopsies of the larynx. Eur Arch Otorhinolaryngol 2006, 263:866-871.
3. Sadri M, McMahon J, Parker A Laryngeal dysplasia: Aetiology and molecular biology. J Laryngol Otol 2006, 120:170-177.
4. Dobrossy L Epidemiology of head and neck cancer: Magnitude of the problem. Cancer Metastasis Rev 2005, 24:9-17.
5. Taylor B, Rehm J When risk factors combine: The interaction between alcohol and smoking for aerodigestive cancer, coronary heart disease, and traffic and fire injury. Addict Behav 2006, 31:1522-1535.
6. Hassan MA, Lund VJ, Howard DJ, et al. Are the demographics for squamous cell cancer in the head and neck changing in the United Kingdom?. J Laryngol Otol 2007, 121:154-157.
7. Moriniere S [Epidemiology of head and neck cancer]. Rev Prat 2006, 56:1637-1641.
8. Thomas G, Hashibe M, Jacob BJ, et al. Risk factors for multiple oral premalignant lesions. Int J Cancer 2003, 107:285-291.
9. Epstein JD, Knight TK, Epstein JB, et al. Cost of care for early- and late-stage oral and pharyngeal cancer in the California medicaid population. Head Neck 2008, 2:178-186.
10. Otoh EC, Johnson NW, Mandong BM, et al. Primary head and neck cancers in Jos, Nigeria: A re-visit. West Afr J Med 2006, 25:92-100.
11. Najeeb T Clinicopathological presentation of tongue cancers and early cancer treatment. J Coll Physicians Surg Pak 2006, 16:179-182.
12. Brouha XD, Tromp DM, de Leeuw JR, et al. Laryngeal cancer patients: Analysis of patient delay at different tumor stages. Head Neck 2005, 27:289-295.
13. Day TA, Chi A, Neville B, et al. Prevention of head and neck cancer. Curr Oncol Rep 2005, 7:145-153.
14. Matthias C [Early detection and prevention of carcinomas of the oral cavity and pharynx]. MMW Fortschr Med 2005, 147:53-55.
15. Sutthavong S, Jansisyanont P, Boonyopastham N Oral health care in head and neck cancer. J Med Assoc Thai 2005, 88(Suppl 3):S339-S353.
16. Barzan L, Talamini R, Franchin G, et al. Changes in presentation and survival of head and neck carcinomas in Northeastern Italy, 1975-1998. Cancer 2002, 95:540-552.
17. Fiorella R, Di Nicola V, Resta L Epidemiological and clinical relief on hyperplastic lesions of the larynx. Acta Otolaryngol Suppl 1997, 527:77-81.
18. Goldman NC Problems in outpatients with laryngeal hyperplastic lesions. Acta Otolaryngol Suppl 1997, 527:70-73.
19. Abbey LM, Kaugars GE, Gunsolley JC, et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995, 80:188-191.
20. Colella G, De Luca F, Lanza A, et al. [The malignant transformation of leukoplakia of the oral cavity. A review of the literature and clinical case reports]. Minerva Stomatol 1995, 44:291-300.
21. Scala M, Moresco L, Comandini D, et al. [The role of the general practitioner and dentist in the early diagnosis of preneoplastic and neoplastic lesions of the oral cavity]. Minerva Stomatol 1997, 46:133-137.
22. Driemel O, Hertel K, Reichert TE, et al. [Current classification of precursor lesions of oral squamous cell carcinoma principles of the WHO classification 2005]. Mund Kiefer Gesichtschir 2006, 10:89-93.
23. Fischer DJ, Epstein JB, Morton TH, et al. Reliability of histologic diagnosis of clinically normal intraoral tissue adjacent to clinically suspicious lesions in former upper aerodigestive tract cancer patients. Oral Oncol 2005, 41:489-496.
24. Fischer DJ, Epstein JB, Morton TH, et al. Interobserver reliability in the histopathologic diagnosis of oral pre-malignant and malignant lesions. J Oral Pathol Med 2004, 33:65-70.
25. Zerdoner D The Ljubljana classification-its application to grading oral epithelial hyperplasia. J Craniomaxillofac Surg 2003, 31:75-79.
26. Nagy P [The Ljubljana classification of epithelial hyperplastic laryngeal lesions]. Orv Hetil 2003, 144:2415-2417.
27. Holmstrup P, Vedtofte P, Reibel J, et al. Long-term treatment outcome of oral premalignant lesions. Oral Oncol 2006, 42:461-474.
28. Scully C, Sudbo J, Speight PM Progress in determining the malignant potential of oral lesions. J Oral Pathol Med 2003, 32:251-256.
29. Nogami T, Kuyama K, Yamamoto H Histopathological and immunohistochemical study of malignant transformation of oral leukoplakia, with special reference to apoptosis-related gene products and proliferative activity. Acta Otolaryngol 2003, 123:767-775.
30. Kujan O, Khattab A, Oliver RJ, et al. Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: An attempt to understand the sources of variation. Oral Oncol 2007, 43:224-231.
31. Warnakulasuriya S Histological grading of oral epithelial dysplasia revisited. J Pathol 2001, 194:294-297.
32. Kurman R, Norris HJ, Wilkinson E Atlas of Tumor Pathology. Tumors of the Cervix, Vagina, and Vulva 1992, 44-55. Armed Forces Institute of Pathology, Washington, DC.
33. van der Waal I, Axell T Oral leukoplakia: A proposal for uniform reporting. Oral Oncol 2002, 38:521-526.
34. Gale N, Kambic V, Michaels L, et al. The Ljubljana classification: A practical strategy for the diagnosis of laryngeal precancerous lesions. Adv Anat Pathol 2000, 7:240-251.
35. Kambic V, Gale N, Ferluga D Laryngeal hyperplastic lesions, follow-up study and application of lectins and anticytokeratins for their evaluation. Pathol Res Pract 1992, 188:1067-1077.
36. Kramer IR, Lucas RB, Pindborg JJ, et al. Definition of leukoplakia and related lesions: An aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978, 46:518-539.
37. Ricci G, Molini E, Faralli M, et al. Retrospective study on precancerous laryngeal lesions: Long-term follow-up. Acta Otorhinolaryngol Ital 2003, 23:362-367.
38. Resta L, Colucci GA, Troia M, et al. Laryngeal intraepithelial neoplasia (LIN). An analytical morphometric approach. Pathol Res Pract 1992, 188:517-523.
39. Hellquist H, Lundgren J, Olofsson J Hyperplasia, keratosis, dysplasia and carcinoma in situ of the vocal cords-a follow-up study. Clin Otolaryngol Allied Sci 1982, 7:11-27.
40. Neumann OG, Franz B [Leukoplakias of the larynx (i. clinical and histological classification) (author's transl)]. Laryngol Rhinol Otol (Stuttg) 1977, 56:828-831.
41. Auerbach O, Hammond EC, Garfinkel L Histologic changes in the larynx in relation to smoking habits. Cancer 1970, 25:92-104.
42. Goodman ML Keratosis (leukoplakia) of the larynx. Otolaryngol Clin North Am 1984, 17:179-183.
43. Norris CM, Peale AR Keratosis of the larynx. J Laryngol Otol 1963, 77:635-647.
44. Pathology and Genetics of Head and Neck Tumours. WHO Classification of Tumours 2005, Vol. No. 9:430. WHO Press, Geneva. L. Barnes, J.W. Eveson, P. Reichart, D. Sidransky (Eds.).
45. Ha PK, Pilkington TA, Westra WH Progression of microsatellite instability from premalignant lesions to tumors of the head and neck. Int J Cancer 2002, 102:615-617.
46. Hunter KD, Thurlow JK, Fleming J, et al. Divergent routes to oral cancer. Cancer Res 2006, 66:7405-7413.
47. Papadimitrakopoulou VA Carcinogenesis of head and neck cancer and the role of chemoprevention in its reversal. Curr Opin Oncol 2000, 12:240-245.
48. Lippman SM, Sudbo J, Hong WK Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol 2005, 23:346-356.
49. Coltrera MD, Zarbo RJ, Sakr WA, et al. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue. Am J Pathol 1992, 141:817-825.
50. Yashima K, Maitra A, Rogers BB, et al. Expression of the RNA 0component of telomerase during human development and differentiation. Cell Growth Differ 1998, 9:805-813.
51. Zidar N, Gale N, Cor A, et al. Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx. J Laryngol Otol 1996, 110:440-445.
52. Browne RM, Potts AJ Dysplasia in salivary gland ducts in sublingual leukoplakia and erythroplakia. Oral Surg Oral Med Oral Pathol 1986, 62:44-49.
53. Sternberg S Histology for Pathologists 1992, 451-455. Raven Press, New York.
54. Nasiell M Metaplasia and atypical metaplasia in the bronchial mucosa: A histopathological and cytopathological study. Acta Cytol 1996, 10:421-427.
55. Stiblar-Martincic D Histology of laryngeal mucosa. Acta Otolaryngol Suppl 1997, 527:137-141.
56. Fechner R, Mills SE Larynx and pharynx. Histopathology for the Pathologist 1996, 443-455. LippincottRaven, New York. S. Sternberg (Ed.).
57. Schwimmer E Die idiopatisches scleimahaut plaques der mundhohle (leukoplakia buccalis). Arch Dermatol Syphilol 1877, 9:511-570.
58. WHO International Histological Classification of Tumors. Histologic Typing of Cancer and Precancer of the Oral Mucosa 1997, Springer, New York. 2nd ed. J. Pindborg, P.A. Reichart, C.J. Smith (Eds.).
59. Banoczy J Follow-up studies in oral leukoplakia. J Maxillofac Surg 1977, 5:69-75.
60. Einhorn J, Wersall J Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa. Cancer 1967, 20:2189-2193.
61. Shafer WG, Waldron CA A clinical and histopathologic study of oral leukoplakia. Surg Gynecol Obstet 1961, 112:411-420.
62. Shklar G Patterns of keratinization in oral leukoplakia. Arch Otolaryngol 1968, 87:400-404.
63. Silverman S, Gorsky M, Lozada F Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984, 53:563-568.
64. Banoczy J, Csiba A Occurrence of epithelial dysplasia in oral leukoplakia. Analysis and follow-up study of 12 cases. Oral Surg Oral Med Oral Pathol 1976, 42:766-774.
65. Waldron CA, Shafer WG Leukoplakia revisited. A clinicopathologic study of 3256 oral leukoplakias. Cancer 1975, 36:1386-1392.
66. Reichart PA, Philipsen HP Oral erythroplakia-a review. Oral Oncol 2005, 41:551-561.
67. Mashberg A Erythroplasia: The earliest sign of asymptomatic oral cancer. J Am Dent Assoc 1978, 96:615-620.
68. Shafer WG, Waldron CA Erythroplakia of the oral cavity. Cancer 1975, 36:1021-1028.
69. Burkhardt A [Premalignant changes in the mouth mucosa. Proposals for nomenclature by an international expert commission]. Pathologe 1985, 6:126-132.
70. Cawson RA, Langdon JD, Eveson JW Erythroplasia ("erythroplakia"). Surgical Pathology of the Mouth and Jaws 1996, 180-182. Wright Publishing, London.
71. Lumerman H, Freedman P, Kerpel S Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995, 79:321-329.
72. Seoane J, Varela-Centelles PI, Diz Dios P, et al. Experimental intervention study about recognition of erythroplakia by undergraduate dental students. Int Dent J 1999, 49:275-278.
73. van der Waal I, Schepman KP, van der Meij EH, et al. Oral leukoplakia: A clinicopathological review. Oral Oncol 1997, 33:291-301.
74. Lingen MW, Kalmar JR, Karrison T, et al. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol 2008, 44:10-22.
75. Brennan M, Migliorati CA, Lockhart PB, et al. Management of oral epithelial dysplasia: A review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 103(Suppl 19):e11-e12.
76. Holmstrup P, Vedtofte P, Reibel J, et al. Oral premalignant lesions: Is a biopsy reliable?. J Oral Pathol Med 2007, 36:262-266.
77. Marcus M, Maida CA, Freed JR, et al. Oral white patches in a national sample of medical HIV patients in the era of HAART. Community Dent Oral Epidemiol 2005, 33:99-106.
78. Brothwell DJ, Lewis DW, Bradley G, et al. Observer agreement in the grading of oral epithelial dysplasia. Community Dent Oral Epidemiol 2003, 31:300-305.
79. Schepman KP, van der Meij EH, Smeele LE, et al. Prevalence study of oral white lesions with special reference to a new definition of oral leucoplakia. Eur J Cancer B Oral Oncol 1996, 32B:416-419.
80. Axell T, Pindborg JJ, Smith CJ, et al. Oral white lesions with special reference to precancerous and tobacco-related lesions: Conclusions of an international symposium held in Uppsala, Sweden, May 18-21, 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med 1996, 25:49-54.
81. Bokor-Bratic M [Prevalence of oral leukoplakia]. Med Pregl 2003, 56:552-555.
82. Patten S Diagnostic Cytopathology of the Uterine Cervix. Basel: Karger 1978.
83. Saccomanno G, Archer VE, Auerbach O, et al. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 1974, 33:256-270.
84. Ali AA, Al-Sharabi AK, Aguirre JM Histopathological changes in oral mucosa due to takhzeen al-qat: A study of 70 biopsies. J Oral Pathol Med 2006, 35:81-85.
85. Ali AA, Al-Sharabi AK, Aguirre JM, et al. A study of 342 oral keratotic white lesions induced by qat chewing among 2500 Yemeni. J Oral Pathol Med 2004, 33:368-372.
86. Sawair FA, Al-Mutwakel A, Al-Eryani K, et al. High relative frequency of oral squamous cell carcinoma in Yemen: Qat and tobacco chewing as its aetiological background. Int J Environ Health Res 2007, 17:185-195.
87. Greenspan D, Greenspan JS, Conant M, et al. Oral "hairy" leucoplakia in male homosexuals: Evidence of association with both papillomavirus and a herpes-group virus. Lancet 1984, 2:831-834.
88. Rosai and Ackerman's Surgical Pathology 2004, Mosby, Philadelphia. 8th ed. J. Rosai (Ed.).
89. Adler-Storthz K, Ficarra G, Woods KV, et al. Prevalence of Epstein-Barr virus and human papillomavirus in oral mucosa of HIV-infected patients. J Oral Pathol Med 1992, 21:164-170.
90. Franceschi S, Dal Maso L, Arniani S, et al. Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Br J Cancer 1998, 78:966-970.
91. Goedert JJ The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol 2000, 27:390-401.
92. Beral V, Newton R Overview of the epidemiology of immunodeficiency-associated cancers. J Natl Cancer Inst Monogr 1998, 23:1-6.
93. Barry B, Gehanno P [Squamous cell carcinoma of the ENT organs in the course of the HIV infection]. Ann Otolaryngol Chir Cervicofac 1999, 116:149-153.
94. Singh B, Sabin S, Rofim O, et al. Alterations in head and neck cancer occurring in HIV-infected patients-results of a pilot, longitudinal, prospective study. Acta Oncol 1999, 38:1047-1050.
95. Silverman S, Gorsky M Proliferative verrucous leukoplakia: A follow-up study of 54 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997, 84:154-157.
96. Gastrointestinal Pathology: An Atlas and Text 1999, Lippincott-Raven, New York. 2nd ed. C.M. Fenoglio-Preiser (Ed.).
97. Eisenberg E Lichen planus and oral cancer: Is there a connection between the two?. J Am Dent Assoc 1992, 123:104-108.
98. Eisenberg E, Krutchkoff DJ Lichenoid lesions of oral mucosa. Diagnostic criteria and their importance in the alleged relationship to oral cancer. Oral Surg Oral Med Oral Pathol 1992, 73:699-704.
99. Zhang L, Cheng X, Li Y, et al. High frequency of allelic loss in dysplastic lichenoid lesions. Lab Invest 2000, 80:233-237.
100. Krutchkoff DJ, Eisenberg E Lichenoid dysplasia: A distinct histopathologic entity. Oral Surg Oral Med Oral Pathol 1985, 60:308-315.
101. King GN, Healy CM, Glover MT, et al. Increased prevalence of dysplastic and malignant lip lesions in renal-transplant recipients. N Engl J Med 1995, 332:1052-1057.
102. Silverman S Observations on the clinical characteristics and natural history of oral leukoplakia. J Am Dent Assoc 1968, 76:772-777.
103. Pindborg JJ, Renstrup G, Poulsen HE, et al. Studies in oral leukoplakias. V. Clinical and histologic signs of malignancy. Acta Odontol Scand 1963, 21:407-414.
104. Banoczy J Oral leukoplakia and other white lesions of the oral mucosa related to dermatological disorders. J Cutan Pathol 1983, 10:238-256.
105. Shear M, Pindborg JJ Verrucous hyperplasia of the oral mucosa. Cancer 1980, 46:1855-1862.
106. Suarez P, Batsakis JG, el-Naggar AK Leukoplakia: Still a gallimaufry or is progress being made? A review. Adv Anat Pathol 1998, 5:137-155.
107. Hansen LS, Olson JA, Silverman S Proliferative verrucous leukoplakia. A long-term study of thirty patients. Oral Surg Oral Med Oral Pathol 1985, 60:285-298.
108. Zakrzewska JM, Lopes V, Speight P, et al. Proliferative verrucous leukoplakia: A report of ten cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996, 82:396-401.
109. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995, 332:429-435.
110. Mashberg A, Feldman LJ Clinical criteria for identifying early oral and oropharyngeal carcinoma Erythroplasia revisited. Am J Surg 1988, 156:273-275.
111. Mashberg A, Morrissey JB, Garfinkel L A study of the appearance of early asymptomatic oral squamous cell carcinoma. Cancer 1973, 32:1436-1445.
112. Shear M Erythroplakia of the mouth. Int Dent J 1972, 22:460-473.
113. Hashibe M, Mathew B, Kuruvilla B, et al. Chewing tobacco, alcohol, and the risk of erythroplakia. Cancer Epidemiol Biomarkers Prev 2000, 9:639-645.
114. Scully C, Felix DH Oral medicine-update for the dental practitioner: Red and pigmented lesions. Br Dent J 2005, 199:639-645.
115. Bouquot JE, Ephros H Erythroplakia: The dangerous red mucosa. Pract Periodont Aesthet Dent 1995, 7:59-68.
116. Zhang H, Chen XM, Li ZH [Clinical analysis of vocal cord leukoplakia in 32 cases]. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2000, 14:22-23.
117. McLaren KM, Burnett RA, Goodlad JR, et al. Consistency of histopathological reporting of laryngeal dysplasia. The Scottish Pathology Consistency Group. Histopathology 2000, 37:460-463.
118. Frangez I, Gale N, Luzar B The interpretation of leukoplakia in laryngeal pathology. Acta Otolaryngol Suppl 1997, 527:142-144.
119. Kambic V Epithelial hyperplastic lesions-a challenging topic in laryngology. Acta Otolaryngol Suppl 1997, 527:7-11.
120. Hellquist H, Cardesa A, Gale N, et al. Criteria for grading in the Ljubljana classification of epithelial hyperplastic laryngeal lesions. A study by members of the Working Group on Epithelial Hyperplastic Laryngeal Lesions of the European Society of Pathology. Histopathology 1999, 34:226-233.
121. Koren R, Kristt D, Shvero J, et al. The spectrum of laryngeal neoplasia: The pathologist's view. Pathol Res Pract 2002, 198:709-715.
122. Cupic H, Kruslin B, Belicza M Epithelial hyperplastic lesions of the larynx in biopsy specimens. Acta Otolaryngol Suppl 1997, 527:103-104.
123. Crissman JD Laryngeal keratosis and subsequent carcinoma. Head Neck Surg 1979, 1:386-391.
124. Crissman JD, Visscher DW, Sarkar FH Premalignant lesions of the upper aerodigestive tract: Biomarkers of genetic alterations, proliferation, and differentiation. J Cell Biochem Suppl 1993, 17F:192-198.
125. Crissman JD, Zarbo RJ Dysplasia, in situ carcinoma, and progression to invasive squamous cell carcinoma of the upper aerodigestive tract. Am J Surg Pathol 1989, 13:5-16.
126. Pierce N Leukoplakia laryngis. Ann Otol Rhinol Laryngol 1920, 29:301-308.
127. Jackson C Cancer of the larynx: Is it preceded by a recognizable precancerous condition?. Ann Surg 1923, 77:1-14.
128. Elman AJ, Goodman M, Wang CC, et al. In situ carcinoma of the vocal cords. Cancer 1979, 43:2422-2428.
129. Rothman K, Keller A The effect of joint exposure to alcohol and tobacco on risk of cancer of the mouth and pharynx. J Chronic Dis 1972, 25:711-716.
130. Winn DM Diet and nutrition in the etiology of oral cancer. Am J Clin Nutr 1995, 61:437S-445S.
131. Guenel P, Chastang JF, Luce D, et al. A study of the interaction of alcohol drinking and tobacco smoking among French cases of laryngeal cancer. J Epidemiol Community Health 1988, 42:350-354.
132. McGavran MH, Bauer WC, Ackerman LV Sebaceous lymphadenoma of the parotid salivary gland. Cancer 1960, 13:1185-1187.
133. Miller AH, Fisher HR Clues to the life history of carcinoma in situ of the larynx. Laryngoscope 1971, 81:1475-1480.
134. Histological Typing of Tumours of the Upper Respiratory Tract and Ear 1991, Springer, New York, WHO International Classification of Tumours. 2nd ed. K. Shanmugaratnam, L.H. Sobin (Eds.).
135. Blackwell KE, Fu YS, Calcaterra TC Laryngeal dysplasia. A clinicopathologic study. Cancer 1995, 75:457-463.
136. Crissman JD, Zarbo RJ, Drozdowicz S, et al. Carcinoma in situ and microinvasive squamous carcinoma of the laryngeal glottis. Arch Otolaryngol Head Neck Surg 1988, 114:299-307.
137. Crissman JD Laryngeal keratosis preceding laryngeal carcinoma. A report of four cases. Arch Otolaryngol 1982, 108:445-448.
138. Blackwell KE, Calcaterra TC, Fu YS Laryngeal dysplasia: Epidemiology and treatment outcome. Ann Otol Rhinol Laryngol 1995, 104:596-602.
139. Kambic V, Gale N Epithelial Hyperplastic Lesions of the Larynx 1995, Elsevier, Amsterdam.
140. Michaels L The Kambic-Gale method of assessment of epithelial hyperplastic lesions of the larynx in comparison with the dysplasia grade method. Acta Otolaryngol Suppl 1997, 527:17-20.
141. Sllamniku B, Bauer W, Painter C, et al. The transformation of laryngeal keratosis into invasive carcinoma. Am J Otolaryngol 1989, 10:42-54.
142. Kleinsasser O Cancer of the larynx. A study of development and early growth. J Otolaryngol Soc Aust 1968, 2:8-12.
143. Doyle PJ, Flores A, Douglas GS Carcinoma in situ of the larynx. Laryngoscope 1977, 87:310-316.
144. Gabriel CE, Jones DG Hyperkeratosis of the larynx. J Laryngol Otol 1973, 87:129-134.
145. Gupta PC, Mehta FS, Daftary DK, et al. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol 1980, 8:283-333.
146. Henry RC The transformation of laryngeal leucoplakia to cancer. J Laryngol Otol 1979, 93:447-459.
147. Shibuya H, Amagasa T, Kan-Ichi S, et al. Leukoplakia-associated multiple carcinomas in patients with tongue carcinoma. Cancer 1986, 57:843-846.
148. Kambic V Difficulties in management of vocal cord precancerous lesions. J Laryngol Otol 1978, 92:305-315.
149. Maran AG, Mackenzie IJ, Stanley RE Carcinoma in situ of the larynx. Head Neck Surg 1984, 7:28-31.
150. Hellquist H, Olofsson J, Grontoft O Carcinoma in situ and severe dysplasia of the vocal cords. A clinicopathological and photometric investigation. Acta Otolaryngol 1981, 92:543-555.
151. Crissman JD, Zarbo RJ Quantitation of DNA ploidy in squamous intraepithelial neoplasia of the laryngeal glottis. Arch Otolaryngol Head Neck Surg 1991, 117:182-188.
152. Grontoft O, Hellquist H, Olofsson J, et al. The DNA content and nuclear size in normal, dysplastic and carcinomatous laryngeal epithelium. A spectrophotometric study. Acta Otolaryngol 1978, 86:473-479.
153. Roed-Petersen B Cancer development in oral leukoplakia: Follow up of 331 patients. J Dent Res 1971, 50:711.
154. Bouquot JE, Weiland LH, Kurland LT Leukoplakia and carcinoma in situ synchronously associated with invasive oral/oropharyngeal carcinoma in Rochester, Minn., 1935-1984. Oral Surg Oral Med Oral Pathol 1988, 65:199-207.
155. Ackerman LV, McGavran GM Proliferating benign and malignant epithelial lesions of the oral cavity. J Oral Surg (Chic) 1958, 16:400-413.
156. Palefsky JM, Silverman S, Abdel-Salaam M, et al. Association between proliferative verrucous leukoplakia and infection with human papillomavirus type 16. J Oral Pathol Med 1995, 24:193-197.
157. Bouquot JE, Kurland LT, Weiland LH Laryngeal keratosis and carcinoma in the Rochester, MN, population 1935-1984. Cancer Detect Prev 1991, 15:83-91.
158. Lundgren J, Olofsson J Malignant tumours in patients with non-invasive squamous cell lesions of the vocal cords. Clin Otolaryngol Allied Sci 1987, 12:39-43.
159. Plch J, Pár I, Navrátilová I, et al. Long term follow-up study of laryngeal precancer. Auris Nasus Larynx 1998, 25:407-412.
160. McGavran MH, Bauer WC, Ogura JH Isolated laryngeal keratosis. Its relations to carcinoma of the larynx based on a clinicopathologic study of 87 consecutive cases with long-term follow-up. Laryngoscope 1960, 70:932-951.
161. Hintz BL, Kagan AR, Nussbaum H, et al. A "watchful waiting" policy for in situ carcinoma of the vocal cords. Arch Otolaryngol 1981, 107:746-751.
162. Gillis TM, Incze J, Strong MS, et al. Natural history and management of keratosis, atypia, carcinoma-in situ, and microinvasive cancer of the larynx. Am J Surg 1983, 146:512-516.
163. Slaughter DP, Southwick HW, Smejkal W Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953, 5:963-968.
164. Bouvier G, Hergenhahn M, Polack A, et al. Characterization of macromolecular lignins as Epstein-Barr virus inducer in foodstuff associated with nasopharyngeal carcinoma risk. Carcinogenesis 1995, 16:1879-1885.
165. Hildesheim A, Levine PH Etiology of nasopharyngeal carcinoma: A review. Epidemiol Rev 1993, 15:466-485.
166. Liebowitz D Nasopharyngeal carcinoma: The Epstein-Barr virus association. Semin Oncol 1994, 21:376-381.
167. Boysen M, Voss R, Solberg LA The nasal mucosa in softwood exposed furniture workers. Acta Otolaryngol 1986, 101:501-508.
168. Duffus JH Epidemiology and the identification of metals as human carcinogens. Sci Prog 1996, 79:311-326.
169. Barnes L, Bedetti C Oncocytic Schneiderian papilloma A reappraisal of cylindrical cell papilloma of the sinonasal tract. Hum Pathol 1984, 15:344-351.
170. Christensen WN, Smith RR Schneiderian papillomas: A clinicopathologic study of 67 cases. Hum Pathol 1986, 17:393-400.
171. von Buchwald C, Bradley PJ Risks of malignancy in inverted papilloma of the nose and paranasal sinuses. Curr Opin Otolaryngol Head Neck Surg 2007, 15:95-98.
172. Pathmanathan R, Prasad U, Sadler R, et al. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995, 333:693-698.
173. Cheung FMF, Pang SW, Yau TK, et al. Nasopharyngeal intraepithelial lesion: Latent Epstein-Barr virus infection with malignant potential. Histopathology 2004, 45:171-179.
174. Pak MW, To KF, Lo YMD, et al. Nasopharyngeal carcinoma in situ (NPCIS)-pathologic and clinical perspectives. Head Neck 2002, 24:989-995.
175. Sheu LF, Chen A, Meng CL, et al. Analysis of bcl-2 expression in normal, inflamed, dysplastic nasopharyngeal epithelia, and nasopharyngeal carcinoma: Association with p53 expression. Hum Pathol 1997, 28:556-562.
176. Califano J, van der Riet P, Westra W Genetic progression model for head and neck cancer: Implications for field cancerization. Cancer Res 1996, 56:2488-2492.
177. Fearon ER, Vogelstein B A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
178. Renan MJ How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog 1993, 7:139-146.
179. Ha PK, Califano JA The molecular biology of laryngeal cancer. Otolaryngol Clin North Am 2002, 35:993-1012.
180. Bockmuhl U, Petersen I DNA ploidy and chromosomal alterations in head and neck squamous cell carcinoma. Virchows Arch 2002, 441:541-550.
181. Forastiere A, Koch W, Trotti A Head and neck cancer. N Engl J Med 2001, 345:1890-1900.
182. Trizna Z, Schantz S Hereditary and environmental factors associated with risk and progression of head and neck cancer. Otolaryngol Clin North Am 1992, 25:1089-1103.
183. Ha PK, Benoit NE, Yochem R A transcriptional progression model for head and neck cancer. Clin Cancer Res 2003, 9:3058-3064.
184. Almadori G, Bussu F, Cadoni G Multistep laryngeal carcinogenesis helps our understanding of the field cancerization phenomenon: A review. Eur J Cancer 2004, 40:2383-2388.
185. Bedi GC, Westra WH, Gabrielson E Multiple head and neck tumors: Evidence for a common clonal origin. Cancer Res 1996, 56:2481-2487.
186. Califano J, Westra WH, Meininger G Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res 2000, 6:347-352.
187. Ha PK, Califano JA The molecular biology of mucosal field cancerization of the head and neck. Oral Biol Med 2003, 14:363-369.
188. Scholes AG, Woolgar JA, Boyle MA Synchronous oral carcinomas: Independent or common clonal origin?. Cancer Res 1998, 58:2003-2006.
189. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 2002, 161:1051-1060.
190. Worsham MJ, Wolman SR Common clonal origin of synchronous primary head and neck squamous cell carcinomas: Analysis by tumor karyotypes and fluorescence in situ hybridization. Hum Pathol 1995, 26:251-261.
191. Mertens F, Jin Y, Heim S, et al. Clonal structural chromosome aberrations in nonneoplastic cells of the skin and upper aerodigestive tract. Genes Chromosomes Cancer 1992, 4:235-240.
192. Teyssier J The chromosomal analysis of human solid tumors. A triple challenge. Cancer Genet Cytogenet 1989, 37:103-125.
193. Voravud N, Shin DM, Ro JY Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. Cancer Res 1993, 53:2874-2883.
194. du Manoir S, Speicher MR, Joos S, et al. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 1993, 90:590-610.
195. Gollin SM Chromosomal alterations in squamous cell carcinomas of the head and neck: Window to the biology of disease. Head Neck 2001, 23:238-253.
196. Kallioniemi OP, Kallioniemi A, Sudar D Comparative genomic hybridization: A rapid new method for detecting and mapping DNA amplification in tumors. Semin Cancer Biol 1993, 4:41-46.
197. Brieger J, Jacob R, Riazimand HS Chromosomal aberrations in premalignant and malignant squamous epithelium. Cancer Genet Cytogenet 2003, 144:148-155.
198. Field JK Genomic instability in squamous cell carcinoma of the head and neck. Anticancer Res 1996, 16:2421-2431.
199. Ai H, Barrera JE, Meyers AD, et al. Chromosomal aneuploidy precedes morphological changes and supports multifocality in head and neck lesions. Laryngoscope 2001, 111:1853-1858.
200. Bracko M Evaluation of DNA content in epithelial hyperplastic lesions of the larynx. Acta Otolaryngol Suppl 1997, 527:62-65.
201. Veltman JA, Bot FJ, Huynen FC Chromosome instability as an indicator of malignant progression in laryngeal mucosa. J Clin Oncol 2000, 18:1644-1651.
202. Knudson AG Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971, 68:820-823.
203. Reibel J Prognosis of oral pre-malignant lesions: Significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 2003, 14:47-62.
204. Rosin MP, Cheng X, Poh C, et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 2000, 6:357-362.
205. Mao L, Lee JS, Fan YH Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 1996, 2:682-685.
206. Sanz-Ortega J, Valor C, Saez MC 3p21, 5q21, 9p21 and 17p13 allelic deletions accumulate in the dysplastic spectrum of laryngeal carcinogenesis and precede malignant transformation. Histol Histopathol 2003, 18:1053-1057.
207. Yoo WJ, Cho SH, Lee YS Loss of heterozygosity on chromosomes 3p, 8p, 9p, and 17p in the progression of squamous cell carcinoma of the larynx. J Korean Med Sci 2004, 19:345-351.
208. Zhang L, Rosin MP Loss of heterozygosity: A potential tool in management of oral premalignant lesions?. J Oral Pathol Med 2001, 30:513-520.
209. Veltman JA, van Weert I, Aubele M Specific steps in aneuploidization correlate with loss of heterozygosity of 9p21, 17p13 and 18q21 in the progression of pre-malignant laryngeal lesions. Int J Cancer 2001, 91:193-199.
210. Boyle JO, Hakim J, Koch W The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993, 53:4477-4480.
211. Hardisson D Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2003, 260:502-508.
212. Koch WM, Brennan JA, Zahurak M p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J Natl Cancer Inst 1996, 88:1580-1586.
213. Hollstein M, Sidransky D, Vogelstein B, et al. p53 mutations in human cancers. Science 1991, 253:49-53.
214. Somers KD, Merrick MA, Lopez ME Frequent p53 mutations in head and neck cancer. Cancer Res 1992, 52:5997-6000.
215. Wallace-Brodeur RR, Lowe SW Clinical implications of p53 mutations. Cell Mol Life Sci 1999, 55:64-75.
216. Kropveld A, Rozemuller EH, Leppers FG Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers. Lab Invest 1999, 79:347-353.
217. Gallo O, Santucci M, Franchi A Cumulative prognostic value of p16/CDKN2 and p53 oncoprotein expression in premalignant laryngeal lesions. J Natl Cancer Inst 1997, 89:1161-1163.
218. Homann N, Nees M, Conradt C Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma. Clin Cancer Res 2001, 7:290-296.
219. Ogden GR, Chisholm DM, Morris AM, et al. Overexpression of p53 in normal oral mucosa of oral cancer patients does not necessarily predict further malignant disease. J Pathol 1997, 182:180-184.
220. Glavac D, Volavšek M, Potocnik U Low microsatellite instability and high loss of heterozygosity rates indicate dominant role of the suppressor pathway in squamous cell carcinoma of head and neck and loss of heterozygosity of 11q14.3 correlates with tumor grade. Cancer Genet Cytogenet 2003, 146:27-32.
221. Izzo JG, Papadimitrakopoulou VA, Li XQ Dysregulated cyclin D1 expression early in head and neck tumorigenesis: In vivo evidence for an association with subsequent gene amplification. Oncogene 1998, 17:2313-2322.
222. Jares P, Fernandez PL, Campo E PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 1994, 54:4813-4817.
223. Volavšek M, Bracko M, Gale N Distribution and prognostic significance of cell cycle proteins in squamous carcinoma of the larynx, hypopharynx and adjacent epithelial hyperplastic lesions. J Laryngol Otol 2003, 117:286-293.
224. Lai S, el-Naggar AK Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas. Lab Invest 1999, 79:255-260.
225. Okami K, Reed AL, Cairns P Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma. Oncogene 1999, 18:3541-3545.
226. Williams ME, Gaffey MJ, Weiss LM Chromosome 11Q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1993, 119:1238-1243.
227. Roh HJ, Shin DM, Lee JS Visualization of the timing of gene amplification during multistep head and neck tumorigenesis. Cancer Res 2000, 60:6496-6502.
228. Geisler SA, Olshan AF GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: A mini-HuGE review. Am J Epidemiol 2001, 154:95-105.
229. Grandis JR, Tweardy DJ Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 1993, 53:3579-3584.
230. Grandis RJ, Tweardy DJ, Melhem MF Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma. Clin Cancer Res 1998, 4:13-20.
231. Meyerson M, Counter CM, Eaton EN hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997, 90:785-795.
232. Dhaene K, Van Marck E, Parwaresch R Telomeres, telomerase and cancer: An up-date. Virchows Arch 2000, 437:1-16.
233. Takakura M, Kyo S, Kanaya T Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 1999, 59:551-557.
234. Luzar B, Poljak M, Gale N Telomerase catalytic subunit in laryngeal carcinogenesis-an immunohistochemical study. Mod Pathol 2005, 18:406-411.
235. Luzar B, Poljak M, Marin IJ Quantitative measurement of telomerase catalytic subunit (hTERT) mRNA in laryngeal squamous cell carcinomas. Anticancer Res 2001, 21:4011-4015.
236. Luzar B, Poljak M, Marin IJ Human telomerase catalytic subunit gene re-expression is an early event in oral carcinogenesis. Histopathology 2004, 45:13-19.
237. Luzar B, Poljak M, Marin IJ, et al. Telomerase reactivation is an early event in laryngeal carcinogenesis. Mod Pathol 2003, 16:841-848.
238. Patel V, Leethanakul C, Gutkind JS New approaches to the understanding of the molecular basis of oral cancer. Crit Rev Oral Biol Med 2001, 12:55-63.
239. Munck-Wikland E, Kuylenstierna R, Lindholm J, Auer G p53 immunostaining and image cytometry DNA analysis in precancerous and cancerous squamous epithelial lesions of the larynx. Head Neck 1997, 19:107-115.
240. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992, 168:357-363.
241. Gerdes J, Lemke H, Baisch H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984, 133:1710-1715.
242. Lindberg K, Rheinwald JG Suprabasal 40 kd keratin (K19) expression as an immunohistologic marker of premalignancy in oral epithelium. Am J Pathol 1989, 134:89-98.
243. Vogelesten B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988, 319:525-532.
244. Gallo O, Franchi A, Chiarelli I, et al. Potential biomarkers in predicting progression of epithelial hyperplastic lesions of the larynx. Acta Otolaryngol Suppl 1997, 527:30-38.
245. Silvestri F, Bussani R, Pavletic N, et al. From epithelial dysplasia to squamous carcinoma of the head and neck region: Evolutive and prognostic histopathological markers. Acta Otolaryngol Suppl 1997, 527:49-51.
246. Gale N, Zidar N, Kambic V, et al. Epidermal growth factor receptor, c-erbB-2 and p53 overexpressions in epithelial hyperplastic lesions of the larynx. Acta Otolaryngol Suppl 1997, 527:105-110.
247. Nadal A, Campo E, Pinto J, et al. p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factors. J Pathol 1995, 175:181-188.
248. Cardesa A, Nadal A, Jares P, et al. Hyperplastic lesions of the larynx. Experience of the Barcelona group. Acta Otolaryngol Suppl 1997, 527:43-46.
249. Hellquist HB Apoptosis in epithelial hyperplastic laryngeal lesions. Acta Otolaryngol Suppl 1997, 527:25-29.
250. Kok K, Naylor SL, Buys CH Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res 1997, 71:27-92.
251. Tseng JE, Kemp BL, Khuri FR, et al. Loss of FHIT is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers. Cancer Res 1999, 59:4798-4803.
252. Sozzi G, Sard L, De Gregorio L, et al. Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res 1997, 57:2121-2123.
253. Nelson HH, Wiencke JK, Gunn L, et al. Chromosome 3p14 alterations in lung cancer: Evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos. Cancer Res 1998, 58:1804-1807.
254. Siprashvili Z, Sozzi G, Barnes LD, et al. Replacement of FHIT in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci USA 1997, 94:13771-13776.
255. Sakr WA, Zarbo RJ, Jacobs JR, et al. Distribution of basement membrane in squamous cell carcinoma of the head and neck. Hum Pathol 1987, 18:1043-1050.
256. Lee JS, Lippman SM, Hong WK, et al. Determination of biomarkers for intermediate end points in chemoprevention trials. Cancer Res 1992, 52:2707s-2710s.
257. Smedts F, Ramaekers F, Robben H, et al. Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia. Am J Pathol 1990, 136:657-668.
258. Ogden GR, Chisholm DM, Adi M, et al. Cytokeratin expression in oral cancer and its relationship to tumor differentiation. J Oral Pathol Med 1993, 22:82-86.
259. Hittelman WN, Voravud N, Shin DM, et al. Early genetic changes during upper aerodigestive tract tumorigenesis. J Cell Biochem Suppl 1993, 17F:233-236.
260. Miyaguchi M, Olofsson J, Hellquist HB Immunohistochemical study of epidermal growth factor receptor in severe dysplasia and carcinoma in situ of the vocal cords. Acta Otolaryngol 1991, 111:149-152.
261. Shin DM, Ro JY, Hong WK, et al. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 1994, 54:3153-3159.
262. Mao L Can molecular assessment improve classification of head and neck premalignancy?. Clin Cancer Res 2000, 6:321-322.